Emerging role of serum biomarkers in neurodegenerative dementias in a diverse context
Faheem Arshad, Sarada Subramanian, Subasree Ramakrishnan, Suvarna Alladi · 2025
Read Emerging role of serum biomarkers in neurodegenerative dementias in a diverse context by Faheem Arshad, Sarada Subramanian, Subasree Ramakrishnan, Suvarna Alladi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714681.txt.
Description
Arshad and co-authors tested two blood markers for dementia diagnosis in India, in a study published in 2025. Dementias overlap in symptoms, so clinical judgment alone mislabels many patients. Brain scans and spinal taps are scarce outside rich centers. Two blood proteins offer a shortcut: one tracks brain inflammation, the other nerve fiber damage. Neither depends on the classic Alzheimer's proteins, so they might separate dementia types instead.
Ninety-nine participants received deep cognitive testing and basic brain imaging. The team compared marker levels between Alzheimer's patients, frontotemporal dementia patients, and controls. Validating the markers in a diverse, lower-resource population is the point: most evidence comes from Western cohorts. A cheap blood test that travels well could transform dementia care in India. The study reports how the pair performed.
Catalog record
| CREATOR | Faheem Arshad, Sarada Subramanian, Subasree Ramakrishnan, Suvarna Alladi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |